Agios Pharmaceuticals reported a gross margin of 93.30% and a net margin of -225.33% for the quarter ended Jun 2026. These financial ratios cover 57 quarters of results from Jun 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2012 | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 59.25% | 92.21% | 85.30% | 90.42% | 90.12% | 83.49% | 91.44% | 91.75% | 92.34% | 82.65% | 91.27% | 88.26% | 87.57% | 86.33% | 86.96% | 90.59% | 93.64% | 93.30% | |||||||||||||||||||||||||||||||||||||||
| EBT Margin | -12,073.44% | -1,717.07% | -2,482.14% | -2,150.44% | -1,471.24% | -1,273.03% | -1,234.27% | -1,350.70% | -1,015.79% | -1,134.03% | 11,167.28% | -982.28% | -1,037.61% | -903.60% | -803.05% | -546.18% | -478.31% | -225.33% | |||||||||||||||||||||||||||||||||||||||
| EBIT Margin | -12,156.85% | -1,749.19% | -2,590.73% | -2,300.97% | -1,615.49% | -1,396.01% | -1,363.66% | -1,496.23% | -1,124.34% | -1,228.29% | -1,146.93% | -1,165.30% | -1,221.97% | -1,020.12% | -907.37% | -608.89% | -530.34% | -247.07% | |||||||||||||||||||||||||||||||||||||||
| EBITDA Margin | -12,156.85% | -1,749.19% | -2,590.73% | -2,300.97% | -1,615.49% | -1,396.01% | -1,363.66% | -1,496.23% | -1,124.34% | -1,228.29% | -1,146.93% | -1,165.30% | -1,221.97% | -1,020.12% | -907.37% | -608.89% | -530.34% | -247.07% | |||||||||||||||||||||||||||||||||||||||
| Operating Margin | -12,156.85% | -1,749.19% | -2,590.73% | -2,300.97% | -1,615.49% | -1,396.01% | -1,363.66% | -1,496.23% | -1,124.34% | -1,228.29% | -1,146.93% | -1,165.30% | -1,221.97% | -1,020.12% | -907.37% | -608.89% | -530.34% | -247.07% | |||||||||||||||||||||||||||||||||||||||
| Net Margin | -12,073.44% | -1,717.07% | -2,482.14% | -2,150.44% | -1,471.24% | -1,273.03% | -1,234.27% | -1,350.70% | -1,015.79% | -1,134.03% | 10,574.69% | -899.56% | -1,037.61% | -903.60% | -803.05% | -541.09% | -478.31% | -225.33% | |||||||||||||||||||||||||||||||||||||||
| FCF Margin | -12,084.01% | -1,364.30% | -2,030.40% | -1,537.73% | -1,704.08% | -994.41% | -838.11% | -1,023.82% | -1,221.25% | -844.42% | -944.19% | -1,250.08% | -1,286.44% | -626.25% | -696.48% | -487.47% | -576.93% | -130.79% | |||||||||||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 3.27M | 4.62M | 6.83M | 9.93M | 13.52M | 16.47M | 18.18M | 21.07M | 23.50M | 25.18M | 27.02M | 28.61M | 30.23M | 31.44M | 32.48M | 34.00M | 32.62M | ||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 1,708.05M | 1,489.62M | 1,386.80M | 1,294.16M | 1,216.39M | 1,209.52M | 1,195.01M | 1,118.23M | 1,046.21M | 972.19M | 893.41M | 811.39M | 1,282.43M | 1,727.50M | 1,609.36M | 1,513.38M | 1,428.47M | 1,341.46M | 1,241.11M | 1,146.71M | |||||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.03 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.05 | 0.09 | ||||||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -28.45 | -18.87 | -15.87 | -12.68 | -17.79 | -16.68 | -15.46 | -18.47 | -15.15 | -12.99 | -19.95 | -25.10 | 2.67 | -19.46 | -18.73 | -17.15 | -22.62 | -14.73 | -20.23 | -21.94 | |||||||||||||||||||||||||||||||||||||
| Price to SalesP/S | 0.00M | 217.71 | 441.53 | 358.59 | 227.45 | 235.16 | 186.93 | 175.40 | 202.64 | 284.67 | 282.63 | 175.04 | 194.37 | 154.99 | 181.63 | 79.68 | 96.77 | 49.43 | |||||||||||||||||||||||||||||||||||||||
| Price to BookP/B | 1.81 | 1.38 | 1.32 | 1.08 | 1.48 | 1.40 | 1.23 | 1.64 | 1.56 | 1.54 | 2.23 | 3.71 | 1.56 | 1.22 | 1.16 | 1.41 | 1.82 | 1.33 | 1.81 | 2.16 | |||||||||||||||||||||||||||||||||||||
| Enterprise Value | 1,259.05M | 765.95M | 671.01M | 395.95M | 824.72M | 762.40M | 536.58M | 875.84M | 735.64M | 468.97M | 1,061.42M | 1,882.56M | 1,528.71M | 984.45M | 802.71M | 991.42M | 1,386.49M | 736.55M | 1,270.48M | 1,594.36M | |||||||||||||||||||||||||||||||||||||
| EV to EBIT | -13.81 | -7.31 | -6.63 | -4.06 | -9.05 | -7.69 | -5.92 | -9.35 | -7.29 | -4.41 | -11.53 | -17.79 | -14.87 | -7.87 | -7.53 | -7.80 | -11.86 | -6.06 | -11.55 | -14.42 | |||||||||||||||||||||||||||||||||||||
| EV to EBITDA | -13.81 | -7.31 | -6.63 | -4.06 | -9.05 | -7.69 | -5.92 | -9.35 | -7.29 | -4.41 | -11.53 | -17.79 | -14.87 | -7.87 | -7.53 | -7.80 | -11.86 | -6.06 | -11.55 | -14.42 | |||||||||||||||||||||||||||||||||||||
| Market Capitalization | 2,525.11M | 1,785.97M | 1,594.54M | 1,215.26M | 1,552.40M | 1,545.51M | 1,275.79M | 1,578.41M | 1,383.13M | 1,245.90M | 1,659.41M | 2,452.45M | 2,533.47M | 1,878.16M | 1,696.08M | 1,930.36M | 2,339.35M | 1,590.97M | 2,007.52M | 2,211.94M | |||||||||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -29.65 | -20.16 | -15.86 | -15.96 | -21.75 | -23.32 | -13.35 | -23.65 | -22.30 | -17.13 | -16.59 | -33.71 | -29.93 | -14.00 | -15.11 | -24.75 | -26.08 | -16.35 | -16.77 | -37.80 | |||||||||||||||||||||||||||||||||||||
| EV to FCF | -14.78 | -8.65 | -6.67 | -5.20 | -11.55 | -11.50 | -5.61 | -13.12 | -11.86 | -6.45 | -10.61 | -25.88 | -18.06 | -7.34 | -7.15 | -12.71 | -15.46 | -7.57 | -10.61 | -27.24 | |||||||||||||||||||||||||||||||||||||
| EV to CFO | -14.78 | -9.11 | -6.87 | -5.33 | -11.56 | -11.52 | -5.64 | -13.12 | -11.93 | -6.47 | -10.63 | -25.93 | -18.15 | -7.39 | -7.20 | -12.85 | -15.73 | -7.66 | -10.68 | -27.82 | |||||||||||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -831.03% | -12,156.85% | -1,749.19% | -2,590.73% | -2,300.97% | -1,615.49% | -1,396.01% | -1,363.66% | -1,496.23% | -1,124.34% | -1,228.29% | -1,146.93% | -1,165.30% | -1,221.97% | -1,020.12% | -907.37% | -608.89% | -530.34% | -247.07% | ||||||||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -22.18% | -26.47% | -28.96% | -31.69% | -33.94% | -33.92% | -32.92% | -35.23% | -38.91% | -43.29% | -46.68% | -54.10% | -34.99% | -25.86% | -28.28% | -31.98% | -35.13% | -37.49% | -40.22% | -42.64% | |||||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | 93.77% | 107.73% | -26.68% | -29.34% | -31.09% | -31.11% | -29.99% | -31.11% | -33.64% | -36.54% | -39.84% | -45.37% | 52.33% | 38.81% | 41.21% | 42.84% | -28.21% | -30.90% | -34.10% | -35.89% |